Delivery Order SPE2DB20D1100-SPE2DB24FB6N4
Award Date
5/6/24
Potential Completion Date
5/7/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,178.84 firm fixed-price delivery order is for the supply of 4,564,402,700 units of the prescription drug Vyvanse (60 mg capsules). The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,370.38 Firm Fixed Price Delivery Order contract is for the supply of 4,567,127,666 units of the 10 mg capsule version of the medication Vyvanse. The contract has a period of performance through February 4, 2025 and does not utilize any set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $4,840.43 contract is for the delivery of 4,564,527,987 units of the drug Vyvanse 30 mg capsules. The contract is a Firm Fixed Price Delivery Order with a completion date of May 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,724.00 firm fixed price delivery order is for the supply of 100 units of the medication Vyvanse 50 mg capsules. The contract has a completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,123.04 firm fixed-price delivery order is for the supply of Vyvanse 10 mg capsules. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,524.90 firm fixed-price delivery order is for the supply of 4,564,337,332 units of Vyvanse 20 mg capsules. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $3,199.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order type with a firm fixed price for the supply of 4,566,136,540 units of the prescription drug Vyvanse 40mg capsules. The award has an ultimate completion date of October 18, 2024 and was issued on October 17, 2024. There was no set-aside designation for this contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.70 fixed-price delivery order is for the supply of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a for-profit organization and major supplier of pharmaceutical products and medical supplies to the U.S. government. The $18,351.91 Firm Fixed Price Delivery Order contract was awarded by the Defense Logistics Agency (DLA) to provide 4,564,933,651 units of the prescription drug VYVANSE 20 MG CAPSULE. The contract has a period of performance through June 18, 2024 and does not have a set-aside...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,741.71 firm fixed-price delivery order is for the supply of 4,566,968,183 units of the drug Vyvanse 30 mg capsules. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...